Getting Mounjaro with no GP contact — what's true and what isn't

The myth that your GP controls access to Mounjaro

The single biggest misunderstanding around this query is the idea that a GP referral is the only door into Mounjaro treatment. It is not. In the NHS, access to tirzepatide follows a structured pathway (specific BMI thresholds, qualifying conditions, waiting lists) and your GP is central to that route. But Mounjaro also has a private licence, and private prescribers operate entirely independently of NHS waiting lists and referral chains.

A GPhC-registered Independent Prescriber at a regulated online pharmacy has the legal authority to assess your suitability, issue a prescription and oversee your treatment from start to finish. Your GP does not need to approve that decision, countersign the prescription or be consulted before you begin. That independence is not a loophole, it is how UK private prescribing has always worked, across everything from travel vaccines to specialist medicines.

The tirzepatide information page on this site covers the licensed clinical criteria in more detail if you want to understand the eligibility picture before you start.

What 'no GP contact' does and doesn't mean in practice

If you access Mounjaro privately through a responsible pharmacy, you can do so without speaking to your GP first. Full stop. Your consultation happens directly with the prescribing team at the pharmacy. At nume, that means a real prescriber reads your answers the same working day, not software, not an auto-approval system.

Where GP contact does come in is notification, not permission. GPhC guidance expects responsible prescribers to inform your registered GP that you have started treatment. This is a patient-safety step: if you later see your GP for something unrelated, they need to know what medicines you are taking. It is worth understanding the difference between informing your GP and needing your GP's sign-off. The former is standard professional practice; the latter is not required in private prescribing.

Some people feel relief at that distinction, particularly those who find it difficult to discuss weight with their GP, or who have been told they don't yet qualify for NHS treatment. That frustration is entirely understandable, and it is exactly why the private route exists. You can read more about how Mounjaro relates to GP practice if you want the full picture.

For context on what private treatment typically costs, the Mounjaro pricing page sets out the market honestly.

The clinical assessment still matters, here's why

No GP contact does not mean no clinical oversight. Mounjaro is a prescription-only medicine under the Human Medicines Regulations 2012, and that classification exists for good reason. Tirzepatide is not suitable for everyone: people with a history of certain thyroid cancers, pancreatitis or specific gastrointestinal conditions need prescriber-level review before starting. Pregnancy, breastfeeding and trying to conceive are all situations where Mounjaro is not recommended. Under-18s are not a licensed group.

The assessment at a regulated pharmacy covers your BMI, relevant health conditions, current medications and your weight history. For women using oral contraceptives, the prescriber will flag that adding a non-oral method of contraception for the first four weeks of treatment (and for four weeks after each dose increase) is advised, because tirzepatide can affect how the pill is absorbed. The NHS medicines page for tirzepatide covers the side-effect profile and key safety considerations clearly.

At nume, identity is verified by photo ID, and weight is confirmed on a live video call. Evidence of current treatment is required for transfer patients. These steps are not bureaucracy, they are what separates a legitimate clinical service from a seller operating outside the supply chain. The MHRA has warned publicly about counterfeit GLP-1 pens sold online and through social media, some of which contained insulin rather than tirzepatide. Buying without any clinical assessment at all is the real risk to avoid.

Aftercare and ongoing prescriber contact

One practical upside of going through a pharmacy-led service rather than a GP-based one: aftercare is built in. When you start Mounjaro privately through a service like nume (sorry, like the Mounjaro service at nume) ongoing support and clinical re-review happen before every repeat order. Dose increases are checked against your progress, not auto-renewed. That means your prescriber stays actively involved, even if your GP never needs to be.

If questions come up between orders, the support team is available seven days a week, and you can also find the Mounjaro contact number on the relevant page if you prefer to reach us that way. Our clinical team handles prescribing decisions and aftercare queries. And if you want to understand what a consultation actually involves before committing, the FAQs lay out the process step by step.

If you are ready to find out whether you are clinically suitable, speak to our prescribers through a free consultation, no GP appointment needed before you begin.